Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Cited In for PubMed (Select 9508206)

1.

Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unit.

Lopes LA, Veroneze I, Burgardt CI, Niebel Stier CJ.

Rev Bras Hematol Hemoter. 2014;36(1):35-42. doi: 10.5581/1516-8484.20140011.

2.

Infection prevention in the cancer center.

Thom KA, Kleinberg M, Roghmann MC.

Clin Infect Dis. 2013 Aug;57(4):579-85. doi: 10.1093/cid/cit290. Epub 2013 May 7. Review.

3.

Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia.

Widjajanto PH, Sumadiono S, Cloos J, Purwanto I, Sutaryo S, Veerman AJ.

J Blood Med. 2013;4:1-9. doi: 10.2147/JBM.S33906. Epub 2013 Feb 1.

4.

Targeting the transposase domain of the DNA repair component Metnase to enhance chemotherapy.

Williamson EA, Damiani L, Leitao A, Hu C, Hathaway H, Oprea T, Sklar L, Shaheen M, Bauman J, Wang W, Nickoloff JA, Lee SH, Hromas R.

Cancer Res. 2012 Dec 1;72(23):6200-8. doi: 10.1158/0008-5472.CAN-12-0313. Epub 2012 Oct 22.

5.

Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

Gafter-Gvili A, Fraser A, Paul M, Vidal L, Lawrie TA, van de Wetering MD, Kremer LC, Leibovici L.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD004386. doi: 10.1002/14651858.CD004386.pub3. Review.

6.

Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.

Lee DG, Kim SH, Kim SY, Kim CJ, Park WB, Song YG, Choi JH.

Korean J Intern Med. 2011 Jun;26(2):220-52. doi: 10.3904/kjim.2011.26.2.220. Epub 2011 Jun 1. Review.

7.

Antibacterial prophylaxis in neutropenic children with cancer.

Barone A.

Pediatr Rep. 2011 Feb 24;3(1):e3. doi: 10.4081/pr.2011.e3.

8.

A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings.

Okera M, Chan S, Dernede U, Larkin J, Popat S, Gilbert D, Jones L, Osuji N, Sykes H, Oakley C, Pickering L, Lofts F, Chowdhury S.

Br J Cancer. 2011 Feb 1;104(3):407-12. doi: 10.1038/sj.bjc.6606059. Epub 2010 Dec 21.

9.
10.

Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting.

Koenig SP, Schackman BR, Riviere C, Leger P, Charles M, Severe P, Lastimoso C, Colucci N, Pape JW, Fitzgerald DW.

Clin Infect Dis. 2010 Sep 1;51(5):600-8. doi: 10.1086/655762.

11.

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young JA, Boeckh MJ; Center for International Blood and Marrow Research; National Marrow Donor program; European Blood and MarrowTransplant Group; American Society of Blood and Marrow Transplantation; Canadian Blood and Marrow Transplant Group; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America; Association of Medical Microbiology and Infectious Disease Canada; Centers for Disease Control and Prevention.

Biol Blood Marrow Transplant. 2009 Oct;15(10):1143-238. doi: 10.1016/j.bbmt.2009.06.019. No abstract available. Erratum in: Biol Blood Marrow Transplant. 2010 Feb;16(2):294. Boeckh, Michael A [corrected to Boeckh, Michael J].

12.

Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia.

Sung L, Gamis A, Alonzo TA, Buxton A, Britton K, Deswarte-Wallace J, Woods WG.

Cancer. 2009 Mar 1;115(5):1100-8. doi: 10.1002/cncr.24107. Erratum in: Cancer. 2009 Jun 15;115(12):2807.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk